These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20429846)

  • 1. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
    du Plessis LH; Kotzé AF; Junginger HE
    Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
    Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
    J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
    Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
    J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
    Mei D; Mao S; Sun W; Wang Y; Kissel T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
    van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
    Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
    J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal toxicity of selected absorption enhancers.
    Haffejee N; Du Plessis J; Müller DG; Schultz C; Kotzé AF; Goosen C
    Pharmazie; 2001 Nov; 56(11):882-8. PubMed ID: 11817176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
    Wu J; Wei W; Wang LY; Su ZG; Ma GH
    Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
    Wu ZH; Ping QN; Lei XM; Li JY; Cai P
    Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia.
    Hamman JH; Stander M; Kotzé AF
    Int J Pharm; 2002 Jan; 232(1-2):235-42. PubMed ID: 11790507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
    Thanou M; Verhoef JC; Marbach P; Junginger HE
    J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
    Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
    Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
    Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.
    Zhang X; Zhang H; Wu Z; Wang Z; Niu H; Li C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):526-34. PubMed ID: 17881202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.